Autoreactive T cells to the P3A+ isoform of AChR α subunit in myasthenia gravis

Journal of Neuroimmunology

Volumn 137, Issue 1-2, 2003, Pages 177-186

  Suzuki, Shigeaki ^a   Tanaka, Kortaro ^a   Yasuoka, Hidekata ^a   Fukuuchi, Yasuo ^a   Kawakami, Yutaka ^a   Kuwana, Masataka ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acetylcholine receptor subunit; Myasthenia gravis; P3A exon; T cell; Thymoma

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ALPHA SUBUNIT; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; HUMAN; IN VITRO STUDY; MALE; MYASTHENIA GRAVIS; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOMA;

EID: 0037376649     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00078-X     Document Type: Article

References (35)

1. Andreetta F., Baggi F., Antozzi C., Torchiana E., Bernasconi P., Simoncini O., Cornelio F., Mantegazza R. Acetylcholine receptor α-subunit isoforms are differentially expressed in thymuses from myasthenic patients. Am. J. Pathol. 150:1997;341-348.
2. Beeson D., Morris A., Vincent A., Newsom-Davis J. The human muscle nicotinic acetylcholine receptor α-subunit exist as two isoforms: a novel exon. EMBO J. 9:1990;2101-2106.
3. Brocke S., Brautbar C., Steinman L., Abramsky O., Rothbard J., Neumann D., Fuchs S., Mozes E. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. J. Clin. Invest. 82:1988;1894-1900.
4. Conti-Fine B.M., Navaneetham D., Karachunski P.I., Raju R., Diethelm-Okita B., Okita D., Howard J. Jr., Wang Z.Y. T cell recognition of the acetylcholine receptor in myasthenia gravis. Ann. N. Y. Acad. Sci. 841:1998;283-308.
5. + T cells from myasthenic patients and healthy subjects of biosynthetic and synthetic sequences of the nicotinic acetylcholine receptor. J. Autoimmun. 11:1998;191-203.
6. Drachman D.B. Myasthenia gravis. N. Engl. J. Med. 330:1994;1797-1810.
7. Fatenejad S., Mamula M.J., Craft J. Role of intermolecular/intrastructural B- and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc. Natl. Acad. Sci. U. S. A. 90:1993;12010-12014.
8. Guyon T., Levasseur P., Truffault F., Cottin C., Gaud C., Berrih-Aknin S. Regulation of acetylcholine receptor α subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction. J. Clin. Invest. 94:1994;16-24.
9. Harcourt G., Batocchi A.P., Hawke S., Beeson D., Pantic N., Jacobson L., Willcox N., Vincent A., Newsom-Davis J. Detection of α subunit isoforms in human muscle acetylcholine receptor by specific T cells from a myasthenia gravis patient. Proc. R. Soc. Lond., B Biol. Sci. 254:1993;1-6.
10. Hawke S., Matsuo H., Nicolle M., Malcherek G., Melms A., Willcox N. Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting. Immunol. Today. 17:1996;307-311.
11. Inoko H., Ota M. PCR-RFLP. Hui K.M., Bidwell J.L. Handbook of HLA Typing Techniques. 1993;9-70 CRC Press, Boca Raton, FL.
12. Jaretzki A. III, Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., Sanders D.B. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 55:2000;16-23.
13. Kanai T., Nomura Y., Segawa M., Takagi K., Senju S., Matsushita S., Nishimura Y. Immuno-suppressive peptides for a human T cell clone autoreactive to a unique acetylcholine receptor α subunit peptide presented by the disease-susceptible HLA-DQ6 in infant-onset myasthenia gravis. Hum. Immunol. 56:1997;28-38.
14. Kawakami Y., Eliyahu S., Delgado C.H., Robbins P.F., Sakaguchi K., Appella E., Yannelli J.R., Adema G.J., Miki T., Rosenberg S.A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3515-3519.
15. Kuwana M., Medsger T.A. Jr., Wright T.M. Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides. Clin. Immunol. Immunopathol. 76:1995;266-278.
16. Kuwana M., Medsger T.A. Jr., Wright T.M. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J. Clin. Invest. 96:1995;586-596.
17. Kuwana M., Medsger T.A. Jr., Wright T.M. Highly restricted TCR-αβ usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope. J. Immunol. 158:1997;485-491.
18. Kuwana M., Kaburaki J., Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J. Clin. Invest. 102:1998;1393-1402.
19. Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J. Exp. Med. 181:1995;1945-1948.
20. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:1992;155-157.
21. Luther M.A., Schoepfer R., Whiting P., Casey B., Blatt Y., Montal M.S., Montal M., Linstrom J. A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. J. Neurosci. 9:1989;1082-1096.
22. MacLennan C., Beeson D., Vincent A., Newsom-Davis J. Human nicotinic acetylcholine receptor α subunit isoforms: origins and expression. Nucleic Acids Res. 21:1993;5463-5467.
23. Maina C.V., Riggs P.D., Grandea A.G. III, Slatko B.E., Moran L.S., Tagliamonte J.A., McReynolds L.A., Guan C.D. An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein. Gene. 74:1988;365-373.
24. Manfredi A.A., Yuen M.H., Moiola L., Protti M.P., Conti-Tronconi B.M. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules. J. Immunol. 152:1994;4165-4174.
25. Matsuo H., Batocchi A.P., Hawke S., Nicolle M., Jacobson L., Vincent A., Newsom-Davis J., Willcox N. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. J. Immunol. 155:1995;3683-3692.
26. Nagvekar N., Moody A.M., Moss P., Roxanis I., Curnow J., Beeson D., Pantic N., Newsom-Davis J., Vincent A., Willcox N. A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4-producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes. J. Clin. Invest. 101:1998;2268-2277.
27. Nagvekar N., Corlett L., Jacobson L.W., Matsuo H., Chalkley R., Driscoll P.C., Deshpande S., Spack E.G., Willcox N. Scanning a DRB3*0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor. J. Immunol. 162:1999;4079-4087.
28. Newland C.F., Beeson D., Vincent A., Newsom-Davis J. Functional and non functional isoforms of the human muscle acetylcholine receptor. J. Physiol. 489:1995;767-778.
29. Noda M., Furutani Y., Takahashi H., Toyosato M., Tanabe T., Shimizu S., Kikyotani S., Kayano T., Hirose T., Inayama S., Numa S. Cloning and sequence analysis of calf cDNA and human genomic DNA encoding α-subunit precursor of muscle acetylcholine receptor. Nature. 305:1983;818-823.
30. Oshima M., Ashizawa T., Pollack M.S., Atassi M.Z. Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the α subunit. Eur. J. Immunol. 20:1990;2563-2569.
31. Suzuki S., Kuwana M., Yasuoka H., Tanaka K., Fukuuchi Y., Kawakami Y. Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis. J. Neurol. Sci. 189:2001;59-64.
32. Wakkach A., Guyon T., Bruand C., Tzartos S., Cohen-Kaminsky S., Berrih-Aknin S. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis. J. Immunol. 157:1996;3752-3760.
33. Wilisch A., Gutsche S., Hoffacker V., Schultz A., Tzartos S., Nix W., Schalke B., Schneider C., Muller-Hermelink H.K., Marx A. Association of acetylcholine receptor α-subunit gene expression in mixed thymoma with myasthenia gravis. Neurology. 52:1999;1460-1466.
34. Willcox N., Baggi F., Batocchi A.P., Beeson D., Harcourt G., Hawke S., Jacobson L., Matsuo H., Moody A.M., Nagvekar N., Nicolle M., Ong B., Pantic N., Newson-Davis J., Vincent A. Approaches for studying the pathogenic T cells in autoimmune patients. Ann. N. Y. Acad. Sci. 68:1993;219-237.
35. Zheng Y., Wheatley L.M., Liu T., Levinson A.I. Acetylcholine receptor alpha subunit mRNA expression in human thymus: augmented expression in myasthenia gravis and upregulation by interferon-γ Clin. Immunol. 91:1999;170-177.